These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 409419)

  • 61. [Effect of piribedil on nocturnal sleep (author's transl)].
    Passouant P; Besset A; Billiard M; Negre C
    Rev Electroencephalogr Neurophysiol Clin; 1978 Sep; 8(3):326-34. PubMed ID: 220684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dopamine and depression: a review of recent evidence. I. Empirical studies.
    Willner P
    Brain Res; 1983 Dec; 287(3):211-24. PubMed ID: 6140979
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Parkinson's disease: search for better therapies.
    Marx JL
    Science; 1979 Feb; 203(4382):737-8. PubMed ID: 419406
    [No Abstract]   [Full Text] [Related]  

  • 65. Bromocriptine.
    Parkes D
    Adv Drug Res; 1977; 12():247-344. PubMed ID: 343528
    [No Abstract]   [Full Text] [Related]  

  • 66. Caffeine and the antiparkinsonian response to levodopa or piribedil.
    Shoulson I; Chase T
    Neurology; 1975 Aug; 25(8):722-4. PubMed ID: 125389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Piribedil, a dopamine agonist, in Parkinson's disease.
    Sweet RD; Wasterlain CG; McDowell FH
    Clin Pharmacol Ther; 1974 Dec; 16(6):1077-82. PubMed ID: 4611465
    [No Abstract]   [Full Text] [Related]  

  • 69. Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.
    Rondot P; Ziegler M
    J Neurol; 1992; 239 Suppl 1():S28-34. PubMed ID: 1634909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
    Shopsin B; Gershon S
    Neuropsychobiology; 1978; 4(1):1-14. PubMed ID: 622219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [International symposium on piribedil].
    ZFA (Stuttgart); 1979 Jan; 55(3):172-4. PubMed ID: 33499
    [No Abstract]   [Full Text] [Related]  

  • 72. Piribedil could modify dopamine turnover in cochleas under noise stimulation.
    Vicente-Torres MA; Gil-Loyzaga P; Fernández P; Arce A; Esquifino A
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(6):322-4. PubMed ID: 8265115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bromocriptine and dopaminergic function in Huntington disease.
    Loeb C; Roccatagliata G; Albano C; Besio G
    Neurology; 1979 May; 29(5):730-4. PubMed ID: 155784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat.
    Reid JL; Lewis PJ; Myers MG
    Neuropharmacology; 1975 Mar; 14(3):215-20. PubMed ID: 1134626
    [No Abstract]   [Full Text] [Related]  

  • 75. [The effect of fominoben on the EEG of Parkinson patients (author's transl)].
    Danielczyk W
    MMW Munch Med Wochenschr; 1976 Aug; 118(34):1057-8. PubMed ID: 134282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical studies with dopamine-receptor stimulants.
    Angrist B; Thompson H; Shopsin B; Gershon S
    Psychopharmacologia; 1975 Nov; 44(3):273-80. PubMed ID: 1208762
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Letter: Effects of low doses of a dopamine-receptor stimulator in mania.
    Post RM; Gerner RH; Carman JS; Bunney WE
    Lancet; 1976 Jan; 1(7952):203-4. PubMed ID: 54723
    [No Abstract]   [Full Text] [Related]  

  • 78. Controlled telethermographic study of the peripheral vasoactivity of oral piribedil.
    Huys J; Brems H; de Schrijver A
    Curr Med Res Opin; 1977; 4(9):654-9. PubMed ID: 338254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Possible applications for dopaminergic agents following traumatic brain injury: part 1.
    Zafonte RD; Lexell J; Cullen N
    J Head Trauma Rehabil; 2000 Oct; 15(5):1179-82. PubMed ID: 10970937
    [No Abstract]   [Full Text] [Related]  

  • 80. Bromocriptine and dopamine receptor hypersensitivity.
    Snider SR
    Neurology; 1979 May; 29(5):758-9. PubMed ID: 571581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.